Tumor necrosis factor ligand superfamily member 14 is a protein that in humans is encoded by the TNFSF14gene. TNFSF14 has also been designated as CD258, as well as LIGHT.
The protein encoded by this gene is a member of the tumor necrosis factor (TNF) ligand family. This protein is a ligand for TNFRSF14, which is a member of the tumor necrosis factor receptor superfamily, and which is also known as a herpesvirus entry mediator ligand (HVEML). This protein may function as a costimulatory factor for the activation of lymphoid cells and as a deterrent to infection by herpesvirus. This protein has been shown to stimulate the proliferation of T cells, and trigger apoptosis of various tumor cells. This protein is also reported to prevent tumor necrosis factor alpha mediated apoptosis in primary hepatocyte. Two alternatively spliced transcript variant encoding distinct isoforms have been reported.
Similar to how CD4 is the primary mediating receptor in HIV infection, the HSV glycoprotein (gD) binds to the HVEM receptor which is demanded by TNFSF14/LIGHT lowering the ability for LIGHT to activate the NFκB pathway. NFκB is a survival factor helping to inhibit apoptosis which triggers a pathway inhibiting caspase 8. When gD from HSV binds to HVEM, LIGHT is non-competitively inhibited from binding, encouraging apoptosis in the infected cell.
^Mauri DN, Ebner R, Montgomery RI, Kochel KD, Cheung TC, Yu GL, Ruben S, Murphy M, Eisenberg RJ, Cohen GH, Spear PG, Ware CF (February 1998). "LIGHT, a new member of the TNF superfamily, and lymphotoxin alpha are ligands for herpesvirus entry mediator". Immunity8 (1): 21–30. doi:10.1016/S1074-7613(00)80455-0. PMID9462508.
^ abWare, Carl (2008). "Chapter 25: TNF-Related Cytokines in Immunity". In Paul, William. Fundamental Immunology (Book) (6th ed.). Philadelphia: Lippincott Williams & Wilkins. pp. 776–801. ISBN0-7817-6519-6.
^ abYu, K Y; Kwon B; Ni J; Zhai Y; Ebner R; Kwon B S (May 1999). "A newly identified member of tumor necrosis factor receptor superfamily (TR6) suppresses LIGHT-mediated apoptosis". J. Biol. Chem. (UNITED STATES) 274 (20): 13733–6. doi:10.1074/jbc.274.20.13733. ISSN0021-9258. PMID10318773.
^Hsu, Tsui-Ling; Chang Yung-Chi; Chen Siu-Ju; Liu Yong-Jun; Chiu Allen W; Chio Chung-Ching; Chen Lieping; Hsieh Shie-Liang (May 2002). "Modulation of dendritic cell differentiation and maturation by decoy receptor 3". J. Immunol. (United States) 168 (10): 4846–53. doi:10.4049/jimmunol.168.10.4846. ISSN0022-1767. PMID11994433.
^ abcKuai, Jun; Nickbarg Elliott; Wooters Joe; Qiu Yongchang; Wang Jack; Lin Lih-Ling (April 2003). "Endogenous association of TRAF2, TRAF3, cIAP1, and Smac with lymphotoxin beta receptor reveals a novel mechanism of apoptosis". J. Biol. Chem. (United States) 278 (16): 14363–9. doi:10.1074/jbc.M208672200. ISSN0021-9258. PMID12571250.
Yang D, Zhai Y, Zhang M (2003). "LIGHT, a new member of the TNF superfamily". J. Biol. Regul. Homeost. Agents16 (3): 206–10. PMID12456019.
Bénichou S, Benmerah A (2003). "[The HIV nef and the Kaposi-sarcoma-associated virus K3/K5 proteins: "parasites"of the endocytosis pathway]". Med Sci (Paris)19 (1): 100–6. doi:10.1051/medsci/2003191100. PMID12836198.
Harrop JA, McDonnell PC, Brigham-Burke M et al. (1998). "Herpesvirus entry mediator ligand (HVEM-L), a novel ligand for HVEM/TR2, stimulates proliferation of T cells and inhibits HT29 cell growth". J. Biol. Chem.273 (42): 27548–56. doi:10.1074/jbc.273.42.27548. PMID9765287.
Yu KY, Kwon B, Ni J et al. (1999). "A newly identified member of tumor necrosis factor receptor superfamily (TR6) suppresses LIGHT-mediated apoptosis". J. Biol. Chem.274 (20): 13733–6. doi:10.1074/jbc.274.20.13733. PMID10318773.
Rooney IA, Butrovich KD, Glass AA et al. (2000). "The lymphotoxin-beta receptor is necessary and sufficient for LIGHT-mediated apoptosis of tumor cells". J. Biol. Chem.275 (19): 14307–15. doi:10.1074/jbc.275.19.14307. PMID10799510.
Morel Y, Schiano de Colella JM, Harrop J et al. (2000). "Reciprocal expression of the TNF family receptor herpes virus entry mediator and its ligand LIGHT on activated T cells: LIGHT down-regulates its own receptor". J. Immunol.165 (8): 4397–404. doi:10.4049/jimmunol.165.8.4397. PMID11035077.
Granger SW, Butrovich KD, Houshmand P et al. (2001). "Genomic characterization of LIGHT reveals linkage to an immune response locus on chromosome 19p13.3 and distinct isoforms generated by alternate splicing or proteolysis". J. Immunol.167 (9): 5122–8. doi:10.4049/jimmunol.167.9.5122. PMID11673523.
Shaikh RB, Santee S, Granger SW et al. (2002). "Constitutive expression of LIGHT on T cells leads to lymphocyte activation, inflammation, and tissue destruction". J. Immunol.167 (11): 6330–7. doi:10.4049/jimmunol.167.11.6330. PMID11714797.
Bobik A, Kalinina N (2002). "Tumor necrosis factor receptor and ligand superfamily family members TNFRSF14 and LIGHT: new players in human atherogenesis". Arterioscler. Thromb. Vasc. Biol.21 (12): 1873–5. PMID11742858.
Castellano R, Van Lint C, Peri V et al. (2003). "Mechanisms regulating expression of the tumor necrosis factor-related light gene. Role of calcium-signaling pathway in the transcriptional control". J. Biol. Chem.277 (45): 42841–51. doi:10.1074/jbc.M207689200. PMID12215452.
Matsui H, Hikichi Y, Tsuji I et al. (2003). "LIGHT, a member of the tumor necrosis factor ligand superfamily, prevents tumor necrosis factor-alpha-mediated human primary hepatocyte apoptosis, but not Fas-mediated apoptosis". J. Biol. Chem.277 (51): 50054–61. doi:10.1074/jbc.M206562200. PMID12393901.